![Douglas Faller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Faller
Directeur Technique/Scientifique/R&D chez
IMUNON, INC.
Fortune : 53 187 $ au 31/07/2026
Profil
Dr. Douglas Faller is a Chief Medical Officer at Imunon, Inc., a Professor at Boston University and a Scientific Founder at Sapientia Pharmaceuticals, Inc. Dr. Faller was previously employed as a Chief Medical Officer by Skyhawk Therapeutics, Inc., a Global Chief Medical Officer by Oryzon Genomics SA, a Chief Medical & Scientific Officer by Viracta Therapeutics, Inc., a Co-Founder by HemaQuest Pharmaceuticals, Inc., a Faculty Member by Dana-Farber Cancer Institute, Inc., a Professor by Harvard Medical School, an Executive Medical Director by Takeda Farmacéutica España SA, a Faculty Member by The University of California, San Francisco, and a Co-Founder by Viracta Subsidiary, Inc. He received his undergraduate degree from Massachusetts Institute of Technology, a graduate degree from The University of California, San Francisco, a doctorate degree from Harvard University and a doctorate degree from Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMUNON, INC. 1,33 % | 14/08/2026 | 33 451 ( 1,33 % ) | 53 187 $ | 31/07/2026 |
Postes actifs de Douglas Faller
| Sociétés | Poste | Début |
|---|---|---|
| IMUNON, INC. | Directeur Technique/Scientifique/R&D | 18/02/2025 |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Sapientia Pharmaceuticals, Inc.
 Sapientia Pharmaceuticals, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Fondateur | - |
Anciens postes connus de Douglas Faller
| Sociétés | Poste | Fin |
|---|---|---|
| ORYZON GENOMICS S.A. | Directeur Technique/Scientifique/R&D | 01/01/2024 |
| VIRACTA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2021 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Skyhawk Therapeutics, Inc.
 Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases | Directeur Technique/Scientifique/R&D | - |
Takeda Farmacéutica España SA
 Takeda Farmacéutica España SA Drugstore ChainsRetail Trade Sales pharmaceutical products | Directeur Technique/Scientifique/R&D | - |
Formation de Douglas Faller
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oryzon Genomics SA
 Oryzon Genomics SA BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops epigenetics-based therapeutics | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HemaQuest Pharmaceuticals, Inc.
 HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Farmacéutica España SA
Takeda Farmacéutica España SA Drugstore ChainsRetail Trade Sales pharmaceutical products | Retail Trade |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
Sapientia Pharmaceuticals, Inc.
Sapientia Pharmaceuticals, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
Skyhawk Therapeutics, Inc.
Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases | Health Technology |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
